N

NovaBay Pharmaceuticals Inc
AMEX:NBY

Watchlist Manager
NovaBay Pharmaceuticals Inc
AMEX:NBY
Watchlist
Price: 13.04 USD -3.05% Market Closed
Market Cap: 1.6B USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of NBY.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NBY Intrinsic Value
Not Available
N
Base Case Scenario
Compare NBY to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Contacts
Loading...
How do you feel about B9P?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
NovaBay Pharmaceuticals Inc

Current Assets 3.6m
Cash & Short-Term Investments 1.8m
Receivables 734k
Other Current Assets 1m
Non-Current Assets 1.8m
PP&E 1.3m
Other Non-Current Assets 477k
Current Liabilities 3.9m
Accounts Payable 1.1m
Accrued Liabilities 896k
Short-Term Debt 1m
Other Current Liabilities 904k
Non-Current Liabilities 1.3m
Other Non-Current Liabilities 1.3m
Efficiency

Free Cash Flow Analysis
NovaBay Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
NovaBay Pharmaceuticals Inc

Revenue
14.2m USD
Cost of Revenue
-6.5m USD
Gross Profit
7.8m USD
Operating Expenses
-16.1m USD
Operating Income
-8.3m USD
Other Expenses
-10.2m USD
Net Income
-18.6m USD
Fundamental Scores

NBY Profitability Score
Profitability Due Diligence

NovaBay Pharmaceuticals Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
Declining Operating Margin
15/100
Profitability
Score

NovaBay Pharmaceuticals Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

NBY Solvency Score
Solvency Due Diligence

NovaBay Pharmaceuticals Inc's solvency score is 24/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Long-Term Solvency
Short-Term Solvency
High D/E
24/100
Solvency
Score

NovaBay Pharmaceuticals Inc's solvency score is 24/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NBY Price Targets Summary
NovaBay Pharmaceuticals Inc

There are no price targets for NBY.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

NovaBay Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for B9P is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y